Narrowband UVB phototherapy for early-stage mycosis fungoides

Gathers R, Scherschun l, Malick F, Fivenson D, Lim H

J Am Acad Dermatol. 2002;47:191-7.

The current list of uses for narrowband UVB phototherapy is in the process of expanding. As this treatment modality becomes more widely utilized, information about additional uses is growing. For example, narrowband UVB phototherapy has proven to be an effective, safe and easily administered treatment option for various dermatoses, such as mycosis fungoides.

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

March 11, 2022

Full Article Yiu Z, Ashcroft D, Evans I, McElhone K, Lunt M, Smith C, Walton S, Murphy R, Reynolds N, Ormerod A, Griffiths C, Warren

Moderate exercise and bright light treatment in overweight and obese individuals

March 11, 2022

Full Article Dunai A, Novak M, Chung S, Kayumov L, Keszei A, Levitan R, Shapiro C Obesity. 2007;15(7):1749-1757. “This randomized, controlled study is the first

Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study

March 11, 2022

Full Article Malanos D Stern R J Am Acad Dermatol. 2007;57(2):231-7. doi:10.1016/j.jaad.2007.04.027 A common fear associated with the use of psoralen plus ultraviolet A (PUVA)

Narrowband UVB phototherapy for early-stage mycosis fungoides

Gathers R, Scherschun l, Malick F, Fivenson D, Lim H

Related Posts

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Moderate exercise and bright light treatment in overweight and obese individuals

Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study

CALL 1-800-DAAVLIN OR FILL OUT THE FORM BELOW

CALL 1-800-DAAVLIN OR
FILL OUT THE FORM BELOW